Hemoglobinopati
Özet
Referanslar
Viprakasit V, Ekwattanakit S. Clinical Classification, Screening and Diagnosis for Thalassemia. Hematol Oncol Clin North Am. 2018;32(2):193-211.
Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011;118(13):3479-3488.
Weatherall DJ. The Evolving Spectrum of the Epidemiology of Thalassemia. Hematol Oncol Clin North Am. 2018 ;32(2):165-175.
Chauhan W, Shoaib S, Fatma R, Zaka-Ur-Rab Z, Afzal M. Beta-thalassemia and the advent of new interventions beyond transfusion and iron chelation. Br J Clin Pharmacol. 2022 Apr 3. doi: 10.1111/bcp.15343. Epub ahead of print. PMID: 35373382.
Grech L, Borg K, Borg J. Novel therapies in β-thalassaemia. Br J Clin Pharmacol. 2022;88(6):2509-2524.
Hoffbrand, A. Victor, et al. Color Atlas of Clinical Hematology: Molecular and Cellular Basis of Disease. John Wiley & Sons, 2019.
Ali S, Mumtaz S, Shakir HA, et al. Current status of beta-thalassemia and its treatment strategies. Mol Genet Genomic Med. 2021;9(12):1788.
Brancaleoni V, Di Pierro E, Motta I, Cappellini MD. Laboratory diagnosis of thalassemia. Int J Lab Hematol. 2016 ;38:32-40.
Ali S, Mumtaz S, Shakir HA, et al. Current status of beta-thalassemia and its treatment strategies. Mol Genet Genomic Med. 2021;9(12):1788.
Vichinsky E. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management. Curr Med Res Opin. 2016;32(1):191-204.
McCavit TL. Sickle cell disease. Pediatr Rev. 2012;33(5):195-204
Referanslar
Viprakasit V, Ekwattanakit S. Clinical Classification, Screening and Diagnosis for Thalassemia. Hematol Oncol Clin North Am. 2018;32(2):193-211.
Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011;118(13):3479-3488.
Weatherall DJ. The Evolving Spectrum of the Epidemiology of Thalassemia. Hematol Oncol Clin North Am. 2018 ;32(2):165-175.
Chauhan W, Shoaib S, Fatma R, Zaka-Ur-Rab Z, Afzal M. Beta-thalassemia and the advent of new interventions beyond transfusion and iron chelation. Br J Clin Pharmacol. 2022 Apr 3. doi: 10.1111/bcp.15343. Epub ahead of print. PMID: 35373382.
Grech L, Borg K, Borg J. Novel therapies in β-thalassaemia. Br J Clin Pharmacol. 2022;88(6):2509-2524.
Hoffbrand, A. Victor, et al. Color Atlas of Clinical Hematology: Molecular and Cellular Basis of Disease. John Wiley & Sons, 2019.
Ali S, Mumtaz S, Shakir HA, et al. Current status of beta-thalassemia and its treatment strategies. Mol Genet Genomic Med. 2021;9(12):1788.
Brancaleoni V, Di Pierro E, Motta I, Cappellini MD. Laboratory diagnosis of thalassemia. Int J Lab Hematol. 2016 ;38:32-40.
Ali S, Mumtaz S, Shakir HA, et al. Current status of beta-thalassemia and its treatment strategies. Mol Genet Genomic Med. 2021;9(12):1788.
Vichinsky E. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management. Curr Med Res Opin. 2016;32(1):191-204.
McCavit TL. Sickle cell disease. Pediatr Rev. 2012;33(5):195-204
